Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

BCTX holding history

BriaCell Therapeutics Corp. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BCTX overviewAll 13F holders of BCTXFull Q2 2026 holdings

Shares (Q2 2026)
1,033
Value
$3.35K
% of portfolio
<0.1%
Quarters held
21
Since Q2 2021
Holdings of BCTX by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,033$3.35K<0.1%−1,988−65.8%ReducedHolders
Q1 20263,021$12.7K<0.1%−480−13.7%ReducedHolders
Q4 20253,501$24.9K<0.1%+3,387+2,971.1%AddedHolders
Q3 2025114$1.25K<0.1%+113+8,669.2%AddedConverted for a 1-for-10 splitHolders
Q2 202513$38<0.1%−580−97.8%ReducedHolders
Q1 2025593$2.16K<0.1%−1,065−64.2%ReducedHolders
Q4 20241,658$937<0.1%−1,000−37.6%ReducedHolders
Q3 20242,658$3.30K<0.1%00.0%UnchangedHolders
Q2 20242,658$3.03K<0.1%−21,006−88.8%ReducedHolders
Q1 202423,664$67.7K<0.1%−41,137−63.5%ReducedHolders
Q4 202364,801$379.1K<0.1%−30,214−31.8%ReducedHolders
Q3 202395,015$593.8K<0.1%+19,787+26.3%AddedHolders
Q2 202375,228$483.0K<0.1%+4,491+6.3%AddedHolders
Q1 202370,737$527.0K<0.1%+66,813+1,702.7%AddedHolders
Q4 20223,924$17.1K<0.1%+947+31.8%AddedHolders
Q3 20222,977$17.0K<0.1%+127+4.5%AddedHolders
Q2 20222,850$16.0K<0.1%−17,408−85.9%ReducedHolders
Q1 202220,258$206.0K<0.1%+11,961+144.2%AddedHolders
Q4 20218,297$68.0K<0.1%+1,036+14.3%AddedHolders
Q3 20217,261$59.0K<0.1%−10,966−60.2%ReducedHolders
Q2 202118,227$97.0K<0.1%+18,227NewHolders